On the occasion of World Heart Day, HCMCT Manipal Hospital, Dwarka (A multi-specialty facility) organised a canvas painting session for all on the theme “All About Heart Health”. The participants painted on a canvas of 20x6 feet. When we speak of heart health, we often
The rising burden of Non-communicable Diseases such as Cardiovascular has called for innovative ways to deal with them. Given the higher incidence of heart problems, providers have started harnessing the power of digital health for its prevention and management. The theme of this year World
Jaslok Hospital & Research Centre has installed a set up for World Heart Day in their hospital to create awareness and promote preventive health for CVD (Cardiovascular diseases) and is organizing an inter corporate fitness challenge with objective to encourage more employees of your organization to
‘’The second wave of the Covid-19 pandemic came as a surprise to many health experts, who had thought that this form of virus was eliminated. The outbreak started in December last year and cases grew exponentially over the next few months.Chronic heart failure (HF) is
India accounts for 60% of the world’s heart disease burden Nearly 50% of recovered Covid patients have reported heart complications Almost 15% of cardio-vascular patients require ventilatory support underlining the continued role of ventilators Fifty per cent of all heart attacks in Indian men
Applied Biosystems MagMax Dx Prefilled Viral/Pathogen Nucleic Acid Isolation Kit isolates and purifies viral RNA and DNA from human saliva, nasopharyngeal and oral pharyngeal swabs Thermo Fisher Scientific, the world leader in serving science, today announced that it will manufacture its Applied Biosystems MagMAX Dx Prefilled
Renowned Cardiac Surgeon Dr. Naresh Trehan - Medanta explains how the virus affects heart patients and answers some of the most frequently asked questions: Does Coronavirus effect Heart patients more severely? Are they more vulnerable to catching the Virus? Compared with a Healthy Heart, people
On Monday, Japanese drugmaker Eisai Co (4523.T) began its application process for its experimental drug for early Alzheimer's disease using an accelerated approval pathway which also helped Eisai's development partner Biogen Inc (BIIB.O) win U.S. approval of its medication in June. The Biogen/Eisai drug Aduhelm was considered to be
On Monday Pfizer Inc (PFE.N) said that it had dosed the first patient in a trial testing a flu vaccine based on messenger RNA, the same technology used in the COVID-19 shots made by the U.S. drugmaker and BioNTech . Conducted in the United States, the early-stage vaccine
According to the analysis of the Covid cases conducted in the state in September has discovered that 7.9% of people who died of Covid were vaccinated with two doses. From which 73.98% were asymptomatic and 52.7% who got admitted in hospitals during this period were unvaccinated. Among the first four
Join 2M+ industry professionals with MedgateToday - curated insights, delivered daily.
